Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Free Subscription
1 Abdom Radiol (NY) |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Evaluation of magnetic resonance imaging for bladder cancer detection following
transurethral resection of bladder tumour (TURBT).
Abdom Radiol (NY). 2024 May 8. doi: 10.1007/s00261-024-04235.
PubMed
Abstract available
Tislelizumab, a novel PD-1 monoclonal antibody in urothelial cancer: A real-world
study.
Actas Urol Esp (Engl Ed). 2024;48:295-303.
PubMed
Abstract available
Multidisciplinary consensus document on the current treatment of bacille
Calmette-Guerin-unresponsive non-muscle invasive bladder tumor.
Actas Urol Esp (Engl Ed). 2024;48:262-272.
PubMed
Abstract available
The Missing Trial Variable: A Case Report on Dietary Modification in a Patient
with Durable Complete Remission After an Immunotherapy Clinical Trial for
Metastatic Bladder Cancer.
Altern Ther Health Med. 2024 May 3:AT9333.
PubMed
Abstract available
[Not Available].
Ann Pathol. 2024;44:183-187.
PubMed
[What contribution can make artificial intelligence to urinary cytology?].
Ann Pathol. 2024;44:195-203.
PubMed
Abstract available
ASO Author Reflections: Advancing Early Outcome Assessment in Robot-Assisted
Radical Cystectomy: RARC Tetrafecta.
Ann Surg Oncol. 2024;31:3908-3909.
PubMed
Effectiveness and Safety of Extended Lymph Node Dissection during Radical Surgery
in Patients with Bladder Cancer: A Meta-Analysis.
Arch Esp Urol. 2024;77:303-314.
PubMed
Abstract available
Does intravesical BCG for bladder cancer protect from COVID-19?
Arch Ital Urol Androl. 2024 May 9:12449. doi: 10.4081/aiua.2024.12449.
PubMed
Abstract available
A case of primary small-cell neuroendocrine carcinoma of the bladder.
Asian J Surg. 2024;47:2421-2422.
PubMed
Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis
of Non-muscle Invasive Bladder Cancer.
Biochem Genet. 2024 May 7. doi: 10.1007/s10528-024-10735.
PubMed
Abstract available
Nomograms for predicting the overall and cancer-specific survival in patients
with non-urothelial carcinoma of the bladder: A population-based study.
Biomol Biomed. 2024;24:633-646.
PubMed
Abstract available
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs
the Xpert(R) BC Monitor.
BJU Int. 2024 May 8. doi: 10.1111/bju.16389.
PubMed
Abstract available
How can we reduce morbidity after robot-assisted radical cystectomy with
intracorporeal neobladder? A report on postoperative complications by the
European Association of Urology Robotic Urology Section Scientific Working Group.
BJU Int. 2024;133:673-677.
PubMed
CRISPR-based gene expression platform for precise regulation of bladder cancer.
Cell Mol Biol Lett. 2024;29:66.
PubMed
Abstract available
Nuclear matrix protein 22 in bladder cancer.
Clin Chim Acta. 2024 May 6:119718. doi: 10.1016/j.cca.2024.119718.
PubMed
Abstract available
CXCL10 could be a prognostic and immunological biomarker in bladder cancer.
Discov Oncol. 2024;15:148.
PubMed
Abstract available
Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers.
Eur Urol Oncol. 2024 May 2:S2588-9311(24)00098-1. doi: 10.1016/j.euo.2024.
PubMed
Comparison of bladder carcinogenesis biomarkers in the urine of traditional
cigarette users and e-cigarette users.
Front Public Health. 2024;12:1385628.
PubMed
Abstract available
miRNA-143 as a potential biomarker in the detection of bladder cancer: a
meta-analysis.
Future Oncol. 2024 May 9. doi: 10.2217/fon-2023-0922.
PubMed
Abstract available
Analysis of Bladder Cancer Staging Prediction Using Deep Residual Neural Network,
Radiomics, and RNA-Seq from High-Definition CT Images.
Genet Res (Camb). 2024;2024:4285171.
PubMed
Abstract available
Stimulator of interferon genes mediated immune senescence reveals the immune
microenvironment and prognostic characteristics of bladder cancer.
Heliyon. 2024;10:e28803.
PubMed
Abstract available
Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17
and CK20/CD44/p53 immunohistochemical panel.
Hum Pathol. 2024;146:43-48.
PubMed
Abstract available
Clinical study of steroid receptors in nonmuscle invasive bladder cancer: A
domain worth revisiting.
Indian J Urol. 2024;40:127-132.
PubMed
Abstract available
Revealing the potential of solute carrier family 31 (copper transporters), member
1: Insights into its role in bladder cancer progression and therapeutic
implications.
Int J Immunopathol Pharmacol. 2024;38:3946320241240706.
PubMed
Abstract available
Practice patterns and survival outcomes for Muscle-Invasive Bladder Cancer:
real-life experience in a general population setting.
Int J Qual Health Care. 2024 May 6:mzae040. doi: 10.1093.
PubMed
Abstract available
A commentary on "A CT-based deep learning model predicts overall survival in
patients with muscle invasive bladder cancer after radical cystectomy: a
multicenter retrospective cohort study".
Int J Surg. 2024 May 3. doi: 10.1097/JS9.0000000000001510.
PubMed
Comment on 'HER2 overexpression predicts pathological T2 stage and improved
survival in de novo muscle-invasive bladder cancer after immediate radical
cystectomy: a retrospective cohort study'.
Int J Surg. 2024 May 3. doi: 10.1097/JS9.0000000000001527.
PubMed
Editorial Comment on Real-world sequential treatment patterns and clinical
outcomes among patients with advanced urothelial carcinoma in Japan.
Int J Urol. 2024;31:559-560.
PubMed
Editorial Comment to Real-world sequential treatment patterns and clinical
outcomes among patients with advanced urothelial carcinoma in Japan.
Int J Urol. 2024;31:560-561.
PubMed
Editorial Comment from Dr Miyake to Effectiveness of adjuvant chemotherapy for
patients who undergo radical cystectomy without neoadjuvant chemotherapy: A
retrospective cohort study of 115 advanced bladder cancer patients with
pathological lymph node
Int J Urol. 2024 May 3. doi: 10.1111/iju.15487.
PubMed
Real-world sequential treatment patterns and clinical outcomes among patients
with advanced urothelial carcinoma in Japan.
Int J Urol. 2024;31:552-559.
PubMed
Abstract available
Development and preliminary evaluation of a novel procedure for creation of an
ileal conduit stoma aimed at preventing parastomal hernia.
Int J Urol. 2024;31:512-518.
PubMed
Abstract available
Applications of artificial intelligence in urologic oncology.
Investig Clin Urol. 2024;65:202-216.
PubMed
Abstract available
Comparative analysis of recurrence rates between intravesical gemcitabine and
bacillus Calmette-Guerin induction therapy following transurethral resection of
bladder tumors in patients with intermediate- and high-risk bladder cancer: A
retrospective m
Investig Clin Urol. 2024;65:248-255.
PubMed
Abstract available
Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant
chemotherapy in muscle invasive bladder cancer patients.
Investig Clin Urol. 2024;65:256-262.
PubMed
Abstract available
Identification and validation of a signature based on myofibroblastic
cancer-associated fibroblast marker genes for predicting prognosis, immune
infiltration, and therapeutic response in bladder cancer.
Investig Clin Urol. 2024;65:263-278.
PubMed
Abstract available
Correlation between urine cytology results on the day after overnight continuous
saline irrigation following transurethral resection of bladder tumor and bladder
tumor recurrence.
Investig Clin Urol. 2024;65:279-285.
PubMed
Abstract available
Erratum: CircNT5E promotes the proliferation and migration of bladder cancer via
sponging miR-502-5p: Erratum.
J Cancer. 2024;15:3152-3153.
PubMed
Abstract available
Translation, Linguistic Validation, and Cultural Adaptation of the Bladder Cancer
Index (BCI) Questionnaire Into the Persian (Farsi) Language and Comparing it With
WHO Quality of Life Questionnaire: An Observational Study.
J Family Reprod Health. 2023;17:128-135.
PubMed
Abstract available
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1
blockade response in urothelial carcinoma.
J Pathol. 2024;263:139-149.
PubMed
Abstract available
Bile Spillage as a Prognostic Factor for Gall Bladder Cancer: A Systematic Review
and Meta-analysis.
J Surg Res. 2024;299:94-102.
PubMed
Abstract available
Efficacy of Intravesical Nadofaragene Firadenovec for Patients with
BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a
Phase 3 Trial.
J Urol. 2024 May 5:101097JU0000000000004020. doi: 10.1097/JU.0000000000004020.
PubMed
Abstract available
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized
Clinical Trial.
J Urol. 2024;211:743-753.
PubMed
Abstract available
Distinct longitudinal patterns of urine tumor DNA in patients undergoing
surveillance for bladder cancer.
Mol Oncol. 2024 May 8. doi: 10.1002/1878-0261.13639.
PubMed
Abstract available
NIR-II light powered hydrogel nanomotor for intravesical instillation with
enhanced bladder cancer therapy.
Nanoscale. 2024 May 8. doi: 10.1039/d4nr01128.
PubMed
Abstract available
POU2F3-positive small cell carcinoma of the bladder: A clinicopathologic analysis
of 4 cases and literature review.
Pathol Res Pract. 2024;257:155296.
PubMed
Abstract available
Cost-effectiveness of avelumab first-line maintenance therapy for adult patients
with locally advanced or metastatic urothelial carcinoma in France.
PLoS One. 2024;19:e0302548.
PubMed
Abstract available
Tumor-neutrophil cross talk orchestrates the tumor microenvironment to determine
the bladder cancer progression.
Proc Natl Acad Sci U S A. 2024;121:e2312855121.
PubMed
Abstract available
Predicting bladder cancer survival with high accuracy: insights from MAPK
pathway-related genes.
Sci Rep. 2024;14:10482.
PubMed
Abstract available
Preoperative smoking and robot-assisted radical cystectomy outcomes &
complications in multicenter KORARC database.
Sci Rep. 2024;14:10550.
PubMed
Abstract available
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder
cancer, are we there yet?
Transl Androl Urol. 2024;13:639-642.
PubMed
Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive
bladder cancer: ready for primetime?
Transl Androl Urol. 2024;13:647-649.
PubMed
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated
radiotherapy a feasible approach when no other local options are available?
Tumori. 2024 May 10:3008916241252326. doi: 10.1177/03008916241252326.
PubMed
Abstract available
Perioperative Outcomes of Open Extra-peritoneal Versus Laparoscopic Radical
Cystoprostatectomy: A single Center Comparative Study.
Urol J. 2024;21:175-181.
PubMed
Abstract available
Contemporary morbidity and mortality of open versus robotic cystectomy for
bladder cancer: An analysis of the National Surgical Quality Improvement Program
(NSQIP) procedure targeted cystectomy database.
Urol Oncol. 2024 May 2:S1078-1439(24)00404-6. doi: 10.1016/j.urolonc.2024.
PubMed
Abstract available
[Multicenter networks, innovative concepts, and basic research-the mixture is
important: report from the 14th symposium of the German Research Group on Bladder
Cancer (DFBK) in Cologne].
Urologie. 2024 May 6. doi: 10.1007/s00120-024-02353.
PubMed
Urinary and household chemical exposures in pet dogs with urothelial cell
carcinoma.
Vet Comp Oncol. 2024;22:217-229.
PubMed
Abstract available
Effective detection of BRAF(V595E) mutation in canine urothelial and prostate
carcinomas using immunohistochemistry.
Vet Comp Oncol. 2024;22:295-302.
PubMed
Abstract available
Pre-first-line chemotherapy risk stratification for overall survival in advanced
urothelial carcinoma in sequential therapy era.
World J Urol. 2024;42:307.
PubMed
Abstract available
Thank you for your interest in scientific medicine.